# Adjuvanted Influenza Vaccine in Stem Cell Transplant

> **NCT02560909** · PHASE4 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 73 (actual)

## Conditions studied

- Transplantation
- Influenza Vaccines

## Interventions

- **BIOLOGICAL:** FLUAD® influenza vaccine
- **BIOLOGICAL:** FLUVIRAL®

## Key facts

- **NCT ID:** NCT02560909
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2016-02
- **Final completion:** 2016-08
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2017-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02560909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02560909, "Adjuvanted Influenza Vaccine in Stem Cell Transplant". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02560909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*